Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1351 to 1400 of 2529

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimenTA515
Cabozantinib for treating medullary thyroid cancerTA516
Physical activity and the environmentNG90
Brodalumab for treating moderate to severe plaque psoriasisTA511
Tivozanib for treating advanced renal cell carcinomaTA512
Obinutuzumab for untreated advanced follicular lymphomaTA513
Attention deficit hyperactivity disorderQS39
Mosaicplasty for symptomatic articular cartilage defects of the kneeHTG463
Laparoscopic mesh pectopexy for apical prolapse of the uterus or vaginaHTG464
Autologous chondrocyte implantation using chondrosphere for treating symptomatic articular cartilage defects of the kneeTA508
Pertuzumab with trastuzumab and docetaxel for treating HER2-positive breast cancerTA509
Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis CTA507
People's experience in adult social care services: improving the experience of care and support for people using adult social care servicesNG86
Coban 2 for venous leg ulcersMIB140
Aortic valve reconstruction with processed bovine pericardiumHTG461
Mental health of adults in contact with the criminal justice systemQS163
Parkinson's diseaseQS164
Strimvelis for treating adenosine deaminase deficiency–severe combined immunodeficiencyHST7
Atrial fibrillationQS93
Pancreatic cancer in adults: diagnosis and managementNG85
Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal womenTA160
Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal womenTA161
Pirfenidone for treating idiopathic pulmonary fibrosisTA504
Intrabeam radiotherapy system for adjuvant treatment of early breast cancerTA501
Ibrutinib for treating relapsed or refractory mantle cell lymphomaTA502
Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancerTA503
EpiFix for chronic woundsMIB139
Minimally invasive percutaneous nephrolitholapaxy medium (MIP-M) for removing kidney stonesMIB138
Sore throat (acute): antimicrobial prescribingNG84
Ceritinib for untreated ALK-positive non-small-cell lung cancerTA500
Lenvatinib with everolimus for previously treated advanced renal cell carcinomaTA498
Glecaprevir–pibrentasvir for treating chronic hepatitis CTA499
Age-related macular degenerationNG82
Plasma EGFR mutation tests for adults with locally advanced or metastatic non-small-cell lung cancerMIB137
MammaTyper in vitro diagnostic test for determining breast cancer subtypesMIB135
TYM smartphone otoscope for imaging and videoing the external ear canal and eardrumMIB134
Golimumab for treating active non-radiographic axial spondyloarthritisTA497
Next-generation sequencing panel for solid tumour cancers in childrenMIB133
Autism spectrum disorder in under 19s: recognition, referral and diagnosisCG128
Palbociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancerTA495
Ribociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancerTA496
Endobronchial valve insertion to reduce lung volume in emphysemaHTG457
Transcutaneous microwave ablation for severe primary axillary hyperhidrosisHTG458
Artificial heart implantation as a bridge to transplantation for end-stage refractory biventricular heart failureHTG459
Subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac deathHTG460
Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system)HTG353
Transvaginal mesh repair of anterior or posterior vaginal wall prolapseHTG456
Naltrexone–bupropion for managing overweight and obesityTA494
Suspected cancerQS124
Point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel diseaseMIB132

Results per page

  1. 10
  2. 25
  3. 50
  4. All